Literature DB >> 21532812

Strategic use of clinical pathways.

Dean H Gesme1, Marian Wiseman.   

Abstract

Clinical pathways are detailed, evidence-based processes for delivering cancer care for specific patient presentations. Some oncologists have embraced clinical pathways, while others resist.

Entities:  

Year:  2011        PMID： 21532812      PMCID： PMC3014512          DOI： 10.1200/JOP.2010.000193

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


  9 in total

1.  Does value mean quality? The payer's perspective.

Authors:  Jennifer L Malin
Journal:  J Oncol Pract       Date:  2013-05       Impact factor: 3.840

2.  Enhancing the Budget Impact Model for Institutional Use: A Tool with Practical Applications for the Hospital Oncology Pharmacy.

Authors:  Lisa M Hess; Frank N Cinfio; Stewart Wetmore; Collin Churchill; Christopher Fausel; Amine Ale-Ali; Steven Gelwicks; Christopher A Bly; Sinem Perk; Robert W Klein
Journal:  Hosp Pharm       Date:  2016-06

3.  Implementation of cancer clinical care pathways: a successful model of collaboration between payers and providers.

Authors:  Bruce A Feinberg; James Lang; James Grzegorczyk; Donna Stark; Thomas Rybarczyk; Thomas Leyden; Joseph Cooper; Thomas Ruane; Scott Milligan; Philip Stella; Jeffrey A Scott
Journal:  J Oncol Pract       Date:  2012-05       Impact factor: 3.840

4.  From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study).

Authors:  Giulia Pasello; Giovanni Vicario; Fable Zustovich; Francesco Oniga; Stefania Gori; Francesco Rosetti; Andrea Bonetti; Adolfo Favaretto; Silvia Toso; Roberta Redelotti; Antonio Santo; Daniele Bernardi; Petros Giovanis; Cristina Oliani; Lorenzo Calvetti; Carlo Gatti; Giovanni Palazzolo; Zora Baretta; Alberto Bortolami; Laura Bonanno; Marco Basso; Jessica Menis; Donatella Da Corte; Stefano Frega; Valentina Guarneri; PierFranco Conte
Journal:  Oncologist       Date:  2019-03-07

5.  Factors influencing the delivery of cancer pathways: a summary of the literature.

Authors:  Syaribah Noor Brice; Paul Harper; Tom Crosby; Daniel Gartner; Edilson Arruda; Tracey England; Emma Aspland; Kieran Foley
Journal:  J Health Organ Manag       Date:  2021-03-24

6.  A dynamic clinical pathway for the treatment of patients with early breast cancer is a tool for better cancer care: implementation and prospective analysis between 2002-2010.

Authors:  Peter A van Dam; Gerda Verheyden; Alessa Sugihara; Xuan B Trinh; Herman Van Der Mussele; Hilde Wuyts; Luc Verkinderen; Jan Hauspy; Peter Vermeulen; Luc Dirix
Journal:  World J Surg Oncol       Date:  2013-03-16       Impact factor: 2.754

Review 7.  Payment Reform: Unprecedented and Evolving Impact on Gynecologic Oncology.

Authors:  Sachin M Apte; Kavita Patel
Journal:  Front Oncol       Date:  2016-04-15       Impact factor: 6.244

8.  Value-Based Care in Lung Cancer.

Authors:  Keith D Eaton; Barbara Jagels; Renato G Martins
Journal:  Oncologist       Date:  2016-06-02

9.  Longitudinal cohort study to determine effectiveness of a novel simulated case and feedback system to improve clinical pathway adherence in breast, lung and GI cancers.

Authors:  Timothy Kubal; Doug G Letson; Alberto A Chiappori; Gregory M Springett; Riti Shimkhada; Diana Tamondong Lachica; John W Peabody
Journal:  BMJ Open       Date:  2016-09-13       Impact factor: 2.692
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.